Oral candidiasis in HIV+ patients under treatment with protease inhibitors
The purpose of this work was to evaluate the influence of Protease Inhibitors (PI) on the occurrence of oral candidiasis in 111 HIV+ patients under PI therapy (Group A). The controls consisted of 56 patients that were not using PI drugs (Group B) and 26 patients that were not using any drugs for HIV...
Main Authors: | Andréa Lusvarghi Witzel, Fernando Ricardo Xavier da Silveira, Maria de Fátima Costa Pires, Mônica Andrade Lotufo |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Pesquisa Odontológica
2008-12-01
|
Series: | Brazilian Oral Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242008000400015 |
Similar Items
-
Combination of Antifungal Drugs and Protease Inhibitors Prevent Candida albicans Biofilm Formation and Disrupt Mature Biofilms
by: Matthew B. Lohse, et al.
Published: (2020-05-01) -
Repositioning Lopinavir, an HIV Protease Inhibitor, as a Promising Antifungal Drug: Lessons Learned from <i>Candida albicans</i>—In Silico, In Vitro and In Vivo Approaches
by: André L. S. Santos, et al.
Published: (2021-05-01) -
Repurposing HIV Protease Inhibitors Atazanavir and Darunavir as Antifungal Treatments against <i>Candida albicans</i> Infections: An In Vitro and In Vivo Study
by: Juliana de C. Fenley, et al.
Published: (2022-11-01) -
Current and Novel Inhibitors of HIV Protease
by: Jan Konvalinka, et al.
Published: (2009-12-01) -
Sequences Type Analysis of Candida Albicans Isolates from Iranian Human Immunodeficiency Virus Infected Patients with Oral Candidiasis
by: Farzad Katiraee, et al.
Published: (2014-03-01)